Skip to content

Attitudes towards virtual reality for use in skin cancer prevention in healthy adults

Attitudes towards virtual reality for use in skin cancer prevention in healthy adults - a qualitative study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12620000186954
Enrollment
18
Registered
2020-02-19
Start date
2020-08-25
Completion date
2020-09-06
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is aiming to investigate participants thoughts and feedback on new virtual reality technologies to assist with skin cancer eduation. Who is it for? You may be eligible for this study if you are aged 18 years or over and can attend the Queensland University of Technology for a once-off focus group. Study details All participants will complete a 45 minute audio-recorded focus group at the Queensland University of Technology. Discussion includes the concept of sun safety and new virtual reality technologies to assist with skin cancer prevention. This research will be used to influence future design and implementation of products that educate about skin cancer prevention.

Interventions

This is an exploratory qualitative study on patient attitudes towards use of virtual reality technologies in skin cancer prevention. A series of focus groups will be conducted, with each participant to only attend one focus group. Participants will be asked to complete a demographic survey at the beginning of the focus group. The facilitator will follow a semi-structured format and follow the discussion guide. Participants provide verbal feedback during the focus group. Topics in the discussion

This is an exploratory qualitative study on patient attitudes towards use of virtual reality technologies in skin cancer prevention. A series of focus groups will be conducted, with each participant to only attend one focus group. Participants will be asked to complete a demographic survey at the beginning of the focus group. The facilitator will follow a semi-structured format and follow the discussion guide. Participants provide verbal feedback during the focus group. Topics in the discussion guide include current sun protection practices, and participants will be introduced to the virtual reality technology. During the focus group participants will be asked to undertake a virtual reality experience using the provided virtual reality headset (lasts for 5-7 minutes). Participants will then be asked to provide verbal feedback on their experience. The virtual reality experience will explore virtual worlds including elements of the human body as well as movement based activities. Participants remain seated during the virtual reality experience. The assistant facilitator will audio record the focus group and takes notes. Each focus group will last 45 minutes and be held at the Institute of Health and Biomedical Innovation, Kelvin Grove, Brisbane.

Sponsors

Queensland University of Technology
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

aged 18 years of age and over and understand sufficient English to provide informed consent

Exclusion criteria

You are ineligible if you are pregnant or have pre-existing conditions that may affect your virtual reality experience such as vision abnormalities, psychiatric disorders, suffer from a seizure disorder, heart conditions or other serious health conditions. Implanted medical devices such as cardiac pacemakers, hearing aids & defibrillators can be affected by virtual reality components magnetic field and are therefore excluded from this study. You should not use the VR products if you are tired, need sleep, are under the influence of alcohol or drugs, are hung-over, have digestive problems, are under emotional stress or anxiety, or when suffering from cold, flu, headaches, migraines, or earaches, as this can increase your susceptibility to adverse effects.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026